United Therapeutics Corporation · NASDAQ:UTHR

Mahon Paul A sold 8,300 United Therapeutics Corporation shares (Form 4)

Traded Sep 3, 2026 · Filed Sep 3, 2026

On Sep 3, 2026, Mahon Paul A (EVP & GENERAL COUNSEL) sold 8,300 United Therapeutics Corporation shares at an average US$482.03 for US$4M under a trading plan, leaving 45,172 shares. Filed Sep 3, 2026 (Form 4).

Sold
8,300 shares
Price
US$482.03 average (US$478.93 to US$490.89)
Value
US$4M
Holding after
45,172 shares
Trading plan
Yes (Made under a plan set in advance)
Role
EVP & GENERAL COUNSEL

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Sep 3, 2026Common StockOption exercise8,300US$146.0353,472Direct
Sep 3, 2026Common StockSale1,545US$478.9351,927Direct
Sep 3, 2026Common StockSale936US$479.6650,991Direct
Sep 3, 2026Common StockSale2,360US$480.8648,631Direct
Sep 3, 2026Common StockSale1,048US$481.9247,583Direct
Sep 3, 2026Common StockSale160US$482.6647,423Direct
Sep 3, 2026Common StockSale200US$483.8547,223Direct
Sep 3, 2026Common StockSale954US$485.1246,269Direct
Sep 3, 2026Common StockSale598US$486.4745,671Direct
Sep 3, 2026Common StockSale169US$487.3645,502Direct
Sep 3, 2026Common StockSale10US$488.3245,492Direct
Sep 3, 2026Common StockSale320US$490.8945,172Direct

Source

View original at SEC

Related